US Oncology
Daniel S. Lynch appointed to US Oncology board
Published in Pharma Law Weekly, September 12th, 2006
Lynch also has been appointed to the audit committee of the board of directors of each company.
From 2001 until 2005, Lynch was employed by Imclone Systems Incorporated, a publicly traded biotechnology company, serving as its chief financial officer from 2001 until 2003 and as its chief executive officer and a member of its board of directors from 2003 until 2005. Prior to that time, he served as chief financial officer of Derby Cycle Corporation, a designer, manufacturer and marketer of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-09-12)
More Articles from Pharma Law Weekly
- Ariad Pharmaceuticals
Ariad gets patent covering mTOR inhibitors, treatment methods in cancer and restenosis - Arrowhead Research
Arrowhead announces issuance of patent on subsidiary's key technology - Columbia University, U.S.
Recent findings in colon cancer described by researchers from the United States and Taiwan - Costa Brava
Costa Brava Partnership III L.P. files suit against Bradley Pharmaceuticals, Inc. - EntreMed
EntreMed receives composition-of-matter patent for 2ME2 - Food and Drug Administration, U.S.
U.S. FDA warns three pharmacies to stop mass-producing unapproved inhalation drugs - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
